Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01757873 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia
A Phase 2 study, sponsored by Zalicus.
- Completed
- Registry status
- Phase 2
- Development phase
- 144
- Enrollment target
NCT01757873 is a Phase 2 study that has completed, run by Zalicus. The registered enrollment target is 144 participants.
The verdict
NCT01757873, a Phase 2 study, has completed, sponsored by Zalicus.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 144 participants
- Enrollment target
Study Summary
This study will compare Z160 and placebo in patients with Postherpetic Neuralgia for safety and efficacy for a period of 6 weeks.
Interventions
- DRUG Placebo
- DRUG Z160
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2012-12 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01757873
The ClinicalTrials.gov registry entry for NCT01757873 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zalicus, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01757873 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01757873 about?
NCT01757873 is a clinical study titled "Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia". This study will compare Z160 and placebo in patients with Postherpetic Neuralgia for safety and efficacy for a period of 6 weeks.
What is the current status of trial NCT01757873?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 144 participants. The study started on 2012-12. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01757873?
The interventions under investigation include: Placebo (DRUG), Z160 (DRUG).
Who is sponsoring clinical trial NCT01757873?
This trial is sponsored by Zalicus, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.